Testing a blood-membrane target to treat leukemia
Part of Blood & lymphatic, Cancer clinical trials.
This study looks for a specific marker on leukemia cells and uses it to guide treatment. If you qualify, your care team will check whether this target can be detected and used to help treat your leukemia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer (a leukemia or other blood malignancy).
- You are at least 18 years old.
- You must be able to understand and make decisions about study participation.
- You must be able to speak and understand English.
- You cannot be pregnant (or have a pregnancy involving a fetus) during the study.
- You cannot be incarcerated (in prison) to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood samples from people with blood cancers to find markers that might predict how well immunotherapy will work. The goal is to help doctors choose the right treatment for each person.
This study collects blood and bone marrow samples from patients with blood cancers to understand why treatments stop working. It aims to improve future treatments.
This trial is set up to review tumor lab test results to help doctors choose the most appropriate next treatment for people with leukemia that has returned or did not respond. It mainly matters for younger patients who are not already on a standard treatment path.
This study uses advanced tests (genetics and other 'omics' methods) to better understand your leukemia and find a treatment that targets its specific features. It may help if standard treatments haven't worked or stopped working.
This study looks at gene patterns in people with blood cancers to better understand the disease and find possible treatments. If you are being tested for a blood cancer or have a blood cancer that came back or got worse, you may be able to join.
This study looks for early signs of blood cancers in people who have them or are at higher risk, like family members or older adults. It aims to find cancer sooner, which may lead to better outcomes.
Hear when a new Hematological Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.